Warfarin in the Secondary Prevention of Thromboembolism in Atrial Fibrillation
- 1 January 2004
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 22 (10) , 671-683
- https://doi.org/10.2165/00019053-200422100-00005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Substitution of Generic Warfarin for Coumadin in an HMO SettingAnnals of Pharmacotherapy, 2002
- The Sixth (2000) ACCP Guidelines for Antithrombotic Therapy for Prevention and Treatment of ThrombosisChest, 2001
- Are the current bioequivalence standards sufficient for the acceptance of narrow therapeutic index drugs? Utilization of a computer simulated warfarin bioequivalence model.2000
- Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirinBMJ, 1999
- Bleeding During Warfarin and Aspirin Therapy in Patients With Atrial FibrillationArchives of internal medicine (1960), 1999
- Generic WarfarinChest, 1998
- Changes in plasma warfarin levels and variations in steady-state prothrombin timesClinical Pharmacology & Therapeutics, 1995
- Oral AnticoagulantsChest, 1995
- Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral IschemiaNew England Journal of Medicine, 1995
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991